Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD

We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber, Continue reading

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - Generics, FDA | Leave a comment

The Weekly Summary

Left: GOP congressman Scalise shot by assassin, Right: London slum fire

June 12th – June 18th                                 2017

In general news, overseas, a London low-income high-rise tower became an inferno, killing Continue reading

Posted in - The Weekly Summary | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD

The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge Continue reading

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD

Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band, Continue reading

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

The MusiCorps benefit concert 2015

October 16, 2015- by Steven E. Greer, MD

We interviewed the Founder of MusiCorps, Arthur Bloom, and one of the musicians in the band, Continue reading

Posted in - Policy, NIH, Orthopedic surgery, Plastic surgery, Psychology Psychiatry, Trauma Surgery, VA Walter Reed | Leave a comment

Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD

In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez, Continue reading

Posted in - Policy, NYU, Plastic surgery | Leave a comment

The Healthcare Channel hits 10

 February 3, 2017- by Steven E. Greer, MD

I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming Continue reading

Posted in - Opinion | 1 Comment

Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults

June 14, 2017- Interviewed by Steven E. Greer, MD

We interviewed Dennis Villareal, MD, the author of the NEJM paper “Aerobic or Resistance Continue reading

Posted in - NEJM, Bariatric surgery, Baylor, Diabetes and endocrinology, Geriatrics, Internal Medicine | Leave a comment

The FDA’s new Breakthrough status for new drug applications

May 24, 2013- Interviewed by Steven E. Greer, MD

Janet Woodcock, MD, Continue reading

Posted in - Pharma, FDA | Leave a comment

Interview with The Commissioner of the FDA

February 16, 2011- by Steven Greer, MD

In Part 1 of our interview with Margaret Hamburg, MD, The Commissioner of the FDA, she discusses Continue reading

Posted in FDA | Leave a comment

CDER Director Janet Woodcock on new drug safety strategies

November 16, 2010- by Steven E. Greer, MD

We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible Continue reading

Posted in - Pharma, FDA | Leave a comment

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

January 12, 2017- Interviewed by Steven E. Greer, MD

Jonathan Strosberg, MD of Continue reading

Posted in - NEJM, Oncology | Leave a comment

President-elect Trump adopts plan by The Healthcare Channel to bring back drug manufacturing jobs

Update January 11, 2017- By Steven E Greer, MD

Last November, I sent my idea, below, directly to the Commissioner of the FDA, Robert Califf. I also sent it Continue reading

Posted in - Opinion, - Pharma, - Policy, CMS, Congress, FDA | Leave a comment

The Weekly Summary

June 5th – June 11th                                 2017

In general news, UK’s Prime Minister gambled on rushing an election, hoping to gain a majority Continue reading

Posted in - The Weekly Summary | Leave a comment

Insurance companies are not paying for Repatha and Praluent

March 8, 2017- Interviewed by Steven E. Greer, MD

We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite Continue reading

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | 1 Comment

Interview with the CEO of Neovasc, Alexei Marko

Posted in - Medical Devices, Cardiology, FDA | Leave a comment

Interview with Dexcom’s CEO Terry Gregg

August 11, 2014- Interviewed by Steven E. Greer, MD

Above, in Continue reading

Posted in - Medical Devices | Leave a comment

The bionic pancreas data

July 2, 2014- Interviewed by Steven E. Greer, MD

The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” Continue reading

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

The Weekly Summary

May 29th – June 4th                                 2017

In general news, in London, ISIS attacked again, just shortly after the Manchester music Continue reading

Posted in - The Weekly Summary | Leave a comment